KEYNOTE-689: what it means for locally advanced head and neck cancer
Dr. Ravindra Uppaluri, Dr. Dylan Roden, and Dr. Adam Luginbuhl discuss how the KEYNOTE-689 trial is transforming care for locally advanced head and neck cancer,...




We use cookies to improve your experience on our site. By using our site, you consent to cookies.
Manage your cookie preferences below:
Essential cookies enable basic functions and are necessary for the proper function of the website.
These cookies are needed for adding comments on this website.
Google Tag Manager simplifies the management of marketing tags on your website without code changes.